Loading…

Additive effect of tetramethylpyrazine and deferoxamine in the treatment of spinal cord injury caused by aortic cross-clamping in rats

Study design: Tetramethylpyrazine and deferoxamine are effective agents for nerve injury. Experiments in a Sprague–Dawley rat model of spinal cord injury were performed. Objectives: This study investigated the effects of tetramethylpyrazine and deferoxamine on neurological outcome and spinal cord hi...

Full description

Saved in:
Bibliographic Details
Published in:Spinal cord 2011-02, Vol.49 (2), p.302-306
Main Authors: Liang, Y, Yang, Q-H, Yu, X-D, Jiang, D-M
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Study design: Tetramethylpyrazine and deferoxamine are effective agents for nerve injury. Experiments in a Sprague–Dawley rat model of spinal cord injury were performed. Objectives: This study investigated the effects of tetramethylpyrazine and deferoxamine on neurological outcome and spinal cord hisotpathology after transient spinal cord ischemia in rats. Setting: Chongqing Medical University and Third Military Medical University, Chongqing, China. Methods: Spinal cord ischemia was induced in Sprague–Dawley rats by infrarenal aortic occlusion for 30 min followed by 72 h of reperfusion. Animals were divided into a sham group with a sham procedure; control group with aortic occlusion, but no pharmacological intervention applied; and treatment group with aortic occlusion, treated with tetramethylpyrazine and deferoxamine. After 72 h of reperfusion, neurological status was evaluated in the animals. A histopathological study of spinal cords was performed, and glutamate level and metabotropic glutamate receptor-1 (mGluR1) mRNA expression were determined. Results: All animals in the control group were completely paraplegic with 0% recovery. Tarlov criteria were significantly better in the animals treated with tetramethylpyrazine and deferoxamine than that in the control group ( P
ISSN:1362-4393
1476-5624
DOI:10.1038/sc.2010.113